1. Home
  2. FCEL vs ARMP Comparison

FCEL vs ARMP Comparison

Compare FCEL & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FuelCell Energy Inc.

FCEL

FuelCell Energy Inc.

HOLD

Current Price

$7.20

Market Cap

368.5M

Sector

Energy

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$8.08

Market Cap

296.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCEL
ARMP
Founded
1969
N/A
Country
United States
United States
Employees
N/A
75
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
368.5M
296.7M
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
FCEL
ARMP
Price
$7.20
$8.08
Analyst Decision
Hold
Strong Buy
Analyst Count
3
2
Target Price
$9.08
$12.00
AVG Volume (30 Days)
2.6M
43.1K
Earning Date
03-10-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$158,162,000.00
$5,054,000.00
Revenue This Year
$18.91
$4.48
Revenue Next Year
$35.84
N/A
P/E Ratio
N/A
N/A
Revenue Growth
41.05
N/A
52 Week Low
$3.58
$0.90
52 Week High
$11.99
$16.34

Technical Indicators

Market Signals
Indicator
FCEL
ARMP
Relative Strength Index (RSI) 44.08 63.08
Support Level $6.35 $7.44
Resistance Level $7.64 $8.36
Average True Range (ATR) 0.66 0.61
MACD -0.13 0.09
Stochastic Oscillator 24.17 89.18

Price Performance

Historical Comparison
FCEL
ARMP

About FCEL FuelCell Energy Inc.

FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: